Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News
Uncategorized
Samsung Bioepis reaches settlement on aflibercept biosimilar
Under the terms of a settlement and license agreement with Regeneron, Samsung Bioepis will be able to launch Opuviz in the U.S. in January 2027, according to a press release.“As with ranibizumab biosimilars, aflibercept biosimilars have the potential t…
Uncategorized
Judge blocks cuts to public health grants in four states
A U.S. District Court judge in Illinois granted a temporary restraining order to reinstate $602 million in public health grants allocated for four states that the Trump administration had moved to cancel.Last week, the Office of Management and Budget o…
Uncategorized
Oral drug may allow early treatment of diabetic retinopathy
Editor’s note: This is a developing news story. Please check back soon for updates.Some patients with nonproliferative diabetic retinopathy had reduced vascular leakage or macular exudation after being treated orally with danegaptide, according to a st…
Uncategorized
Prevent reverse pupillary block to improve patient comfort
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Jennifer M. Loh, MD, discusses her technique to resolve reverse pupillary block during cataract surgery.“This is a pretty common occurrence in cataract surgery and can occur ma…
Uncategorized
How physicians can maximize their social media presence
MIAMI BEACH, Fla. — Social media is a vital component for running a successful practice that attracts and maintains patients, according to a speaker at South Beach Symposium.“A study from 2019 revealed that almost 80% of Americans have a social media p…